Praxis Precision Medicines, Inc. closed fiscal year 2025 with $937.9M in total assets, $59.8M in total liabilities and $878.1M in shareholder equity. Total assets rose 94.1% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Praxis Precision Medicines, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PRAX Balance Sheet by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY23Filing | FY2210-K | FY2110-K | FY2010-K | FY1910-K |
|---|---|---|---|---|---|---|---|
| Total Assets | $937.9M+94.1% | $483.1M+449.3% | $87.9M-23.6% | $115.1M-60.7% | $292.7M-3.4% | $303.2M+535.7% | $47.7M |
| Total Liabilities | $59.8M+58.7% | $37.7M+106.0% | $18.3M-53.2% | $39.0M-6.9% | $41.9M+166.8% | $15.7M-87.8% | $128.7M |
| Total Equity | $878.1M+97.1% | $445.4M+539.4% | $69.7M-8.5% | $76.1M-69.7% | $250.8M-12.7% | $287.5Mn/m | -$81.0M |
PRAX Balance Sheet by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.3B+231.0% | $1.4B+207.0% | $1.5B+205.0% | $937.9M+94.1% | $396.4M-4.8% | $452.8M+2.7% | $478.7M+91.2% | $483.1M+449.3% | $416.3M+290.0% | $441.1M+230.4% | $250.4M+154.5% | $87.9M-23.6% |
| Total Liabilities | $52.5M-0.7% | $49.1M+0.9% | $50.2M+27.1% | $59.8M+58.7% | $52.9M+57.4% | $48.6M+121.3% | $39.5M+90.7% | $37.7M+106.0% | $33.6M+68.2% | $22.0M-21.2% | $20.7M-38.9% | $18.3M-53.2% |
| Total Equity | $1.3B+266.7% | $1.3B+231.8% | $1.4B+221.0% | $878.1M+97.1% | $343.5M-10.2% | $404.2M-3.5% | $439.2M+91.2% | $445.4M+539.4% | $382.7M+341.1% | $419.1M+296.8% | $229.7M+256.3% | $69.7M-8.5% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Praxis Precision Medicines, Inc. financials
Frequently Asked Questions
Praxis Precision Medicines, Inc. closed fiscal year 2025 with $937.9M in total assets, $59.8M in total liabilities and $878.1M in shareholder equity.
Praxis Precision Medicines, Inc. (PRAX) total assets rose by 94.1% year over year, from $483.1M to $937.9M in fiscal year 2025.
Across the 7 fiscal years this page covers, Praxis Precision Medicines, Inc. (PRAX) total assets went from $47.7M in fiscal year 2019 to $937.9M in fiscal year 2025.
Praxis Precision Medicines, Inc. (PRAX) reported $1.3B in total assets in Q3 2026. This represents an increase of 231.0% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Praxis Precision Medicines, Inc. (PRAX) reported on that line in every period on record.